Table 1.
Baseline characteristics of study patients (percentages of patients in categorical variables were calculated for each group)
| Overall | HA group | Control group | P valuea | |
|---|---|---|---|---|
| Demographic characteristics | ||||
| Age (years), mean (SD) | 40.2 (12.4) | 42.3 (11.5) | 38.0 (13.1) | 0.113 |
| BMI (kg/m2), mean (SD) | 24.5 (3.3) | 24.6 (3.31) | 24.5 (3.3) | 0.886 |
| Sex, n (%) | ||||
| Males | 44 (53%) | 24 (59%) | 20 (48%) | 0.382 |
| Females | 39 (47%) | 17 (41%) | 22 (52%) | |
| Clinical characteristics | ||||
| Affected shoulder, n (%) | ||||
| Right | 52 (62%) | 27 (64%) | 25 (60%) | 0.822 |
| Left | 32 (38%) | 15 (36%) | 17 (40%) | |
| VAS, mean (SD) | 7.22 (0.95) | 7.33 (0.88) | 7.11 (1.01) | 0.286 |
| ADL, mean (SD) | 17.2 (4.3) | 16.9 (3.7) | 17.5 (4.7) | 0.491 |
| TSK, mean (SD) | 27.6 (4.7) | 29.8 (4.3) | 25.4 (4.1) | <0.001 |
| NSAID consumption during the last month, n (%) | ||||
| Any consumption | 43 (51%) | 24 (57%) | 19 (45%) | 0.382 |
| Frequency | ||||
| Often | 8 (10%) | 6 (14%) | 2 (5%) | 0.281 |
| Occasionally | 35 (42%) | 18 (43%) | 17 (40%) | |
aThe P values correspond to the comparison between the HA group and the control group (T test for quantitative variables and Fisher’s test for categorical variables)